<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04987918</url>
  </required_header>
  <id_info>
    <org_study_id>GZL-FC10-PTL-0001</org_study_id>
    <nct_id>NCT04987918</nct_id>
  </id_info>
  <brief_title>Gazelle COVID-19 Test Clinical Accuracy Protocol</brief_title>
  <official_title>Gazelle COVID-19 Test Clinical Accuracy Protocol</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hemex Health</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hemex Health</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Gazelle COVID-19 is a fluorescent lateral flow immunoassay and accompanying Reader intended&#xD;
      for the qualitative detection of nucleocapsid antigen from SARS-CoV-2 in nasal swab specimens&#xD;
      from individuals who are suspected of COVID-19 by their healthcare provider within 5 days of&#xD;
      symptom onset. The study will be conducted To obtain data to measure the positive percent&#xD;
      agreement and negative percent agreement of the Gazelle COVID-19 Test compared to Reverse&#xD;
      Transcriptase Polymerase Chain Reaction (RT-PCR).The study will assess Gazelle COVID-19 Test&#xD;
      performance using dual mid-turbinate nasal swab samples. This study will primarily assess&#xD;
      Gazelle COVID-19 Test performance on symptomatic subjects (within five days of onset of&#xD;
      symptoms) at point of care (POC). A subset of asymptomatic subjects will be enrolled after&#xD;
      the symptomatic subject enrollment is complete.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">August 9, 2021</start_date>
  <completion_date type="Anticipated">March 15, 2022</completion_date>
  <primary_completion_date type="Anticipated">February 16, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Positive percent agreement and negative percent agreement of the Gazelle COVID-19 Test compared to Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) will be measured</measure>
    <time_frame>3 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Sensitivity and specificity on at least 30, maximum 65, SARS-CoV-2 positive patient samples will be assessed</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">1500</enrollment>
  <condition>Covid19</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Applied Biosystems TaqPath COVID- 19 Combo Kit</intervention_name>
    <description>Reverse Transcriptase Polymerase Chain Reaction (RT-PCR)</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Consecutive subjects of all ages who visit the facility for covid 19 testing (symptomatic&#xD;
        and asymptomatic).&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Symptomatic study:&#xD;
&#xD;
        Inclusion Criteria:&#xD;
&#xD;
        The presence of clinical signs and symptoms consistent with COVID-19. Signs and symptoms&#xD;
        include:&#xD;
&#xD;
          -  Fever&#xD;
&#xD;
          -  Coughing&#xD;
&#xD;
          -  Shortness of breath&#xD;
&#xD;
          -  Recent loss of sense of smell or taste&#xD;
&#xD;
          -  Chills&#xD;
&#xD;
          -  Repeated shaking with chills&#xD;
&#xD;
          -  Muscle pain&#xD;
&#xD;
          -  Headache&#xD;
&#xD;
          -  Sore throat&#xD;
&#xD;
          -  Vomiting or diarrhea&#xD;
&#xD;
               -  Within 1-5 days of symptom onset&#xD;
&#xD;
               -  Informed consent for all the samples will be obtained from the subject or&#xD;
                  obtained from the parent/guardian in case the patient is a minor&#xD;
&#xD;
               -  All ages&#xD;
&#xD;
               -  All genders&#xD;
&#xD;
               -  Pregnant women&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Severe disease requiring immediate medical intervention&#xD;
&#xD;
          -  Inability to tolerate sampling procedure (nasal swab)&#xD;
&#xD;
          -  Failure to provide informed consent&#xD;
&#xD;
          -  Nasal deformities preventing sampling by swab&#xD;
&#xD;
          -  Ongoing nosebleeds or use of a nasal spray within the last 4 hours.&#xD;
&#xD;
          -  Asymptomatic patients&#xD;
&#xD;
        Asymptomatic study:&#xD;
&#xD;
        Inclusion criteria:&#xD;
&#xD;
          -  Present to the facility for a COVID-19 test without symptoms&#xD;
&#xD;
          -  Informed consent for all specimens will be obtained from the patient or obtained from&#xD;
             the parent/guardian in case the patient is a minor&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Exclusion criteria include one or more of the following:&#xD;
&#xD;
          -  Severe disease requiring immediate medical intervention&#xD;
&#xD;
          -  Inability to tolerate sampling procedure&#xD;
&#xD;
          -  Is below 2 years old&#xD;
&#xD;
          -  Failure to provide informed consent&#xD;
&#xD;
          -  Nasal deformities preventing sampling by swab&#xD;
&#xD;
          -  Ongoing nosebleeds or use of a nasal spray within the last 4 hours.&#xD;
&#xD;
          -  Presence of typical symptoms of COVID-19 (fever, sore throat, fatigue, etc.)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ryan Robert Fortna, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Northwest Pathology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>PRIYA THOTA, MD</last_name>
    <phone>2162339405</phone>
    <email>p.thota@hemexhealth.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>David Bell, MD</last_name>
    <email>d.bell@hemexhealth.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Northwest Pathology drive thru site, Bellingham International Airport</name>
      <address>
        <city>Bellingham</city>
        <state>Washington</state>
        <zip>98226</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Bri Spencer</last_name>
      <email>Bri.Spencer@nwlaboratory.com</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>July 30, 2021</study_first_submitted>
  <study_first_submitted_qc>July 30, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 3, 2021</study_first_posted>
  <last_update_submitted>August 4, 2021</last_update_submitted>
  <last_update_submitted_qc>August 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>COVID-19</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

